Dr De Armas Jimenez faced four charges against him, that:
On or around 22 April 2022 or 23 April 2022, in relation to a cat, he a) failed to obtain informed consent to sedate/anaesthetise the cat and/or did so without the owner’s consent (admitted), b) failed to take adequate steps when the cat required emergency attention (admitted), and c) failed to provide adequate details to the owner following the cat’s death (admitted).
On or around 22 April 2022 or 23 April 2022, he a) failed to record adequate clinical record details of the cat’s sedation/anaesthetic (admitted), b) recorded when the cat became cyanotic, that i) a tube had been passed in order to intubate (proved not to have occured) and ii) chest compressions had been given when this was not the case (not proved that it did not happen), and c) failed to make adequate clinical records in relation to differential diagnoses and proposed treatment plan (not proved).
That his conduct in relation to charge 2(a) and/or 2(b) was a) dishonest and/or b) misleading. (Admitted his conduct was both dishonest and misleading in relation to 2(a), and the Committee found proved that his conduct was dishonest and/or misleading in relation to 2(b)(i)).
Between 22 April 2022 and 23 April 2022, he failed to have any professional indemnity insurance in place (admitted).
Dr De Armas Jimenez admitted most of the charges again him.
The Committee found that his actions had breached a number of sections of the RCVS Code of Conduct for Veterinary Surgeons and amounted to serious professional misconduct.
In deciding on a sanction, the Committee took into account the aggravating factor that Dr De Armas Jimenez had caused actual harm to the animal.
Mitigating factors included that he had no previous disciplinary history, that he had been working for eight years as a veterinary surgeon in the UK without complaint, that he admitted most of the charges, that he'd made subsequent efforts to avoid repetition by no longer working night shifts or locuming, and finally that the incident related to one animal.
The Committee also noted that he'd shown appreciable insight and remorse, and took into account positive character references.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “Whilst the misconduct in this case involved breaches of the RCVS Code, caused serious harm to both the cat and the client, and involved dishonesty which was concealed, the Committee decided that a lengthy suspension could take account of the seriousness of these matters and meet the wider public interest.”
He added: “In deciding on this period of suspension, the Committee took into account both mitigating and aggravating factors and the mitigation Dr De Armas Jimenez had put before it.
"It was not persuaded that a shorter period of suspension would properly reflect the seriousness of the proven misconduct.
"It concluded that this period of suspension had a deterrent effect and sent a signal as to how serious the Committee had found the misconduct to be.
"It also took into account Dr De Armas Jimenez’s remorse and insight.
“However, in order that the wider public interest was upheld and to reflect the Committee’s view regarding the seriousness of the proven misconduct, the Committee determined that the proportionate sanction and period of suspension should be a suspension order of eight months.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
This, say the researchers, is the first time in a UK field setting that the effect of early-life exposures, in particular exercise and turn out, on later-life milestones and race performance in Thoroughbreds has been comprehensively evaluated.
The findings can be applied at stud farms to help retain Thoroughbreds within the industry and achieve their athletic potential - outcomes that align with priorities of the Horse Welfare Board’s strategy to support the welfare of horses bred for racing.
The research team, led by Rebecca Mouncey MRCVS, a Post-Doctoral Research Fellow at the RVC, followed 129 flat race bred Thoroughbred foals, born in 2019 and 2020 on six stud farms across the UK, from birth into training for racing.
Each dam’s reproductive history, and details of her health and management during pregnancy were collected, as were daily records of the foal’s health and management from birth until they left the stud farm.
Race performance records up to the end of their fourth year of life were collated from racing industry databases.
The team then used statistical modelling to evaluate relationships between gestational exposures and early-life experiences and whether or not horses entered training and their subsequent race performance.
Findings suggested that the use of more extensive turnout practices during the first six months of life and later weaning benefited the attainment of career milestones, productivity (the number of races) and financial returns (total prizemoney won).
The main findings were:
The findings demonstrate that the first six months of life is a critical period of development in Thoroughbreds, during which it is essential that turnout and weaning practices provide sufficient opportunity for positive tissue adaptation and optimal development.
Breeders are therefore encouraged to maximise turnout whenever possible, and to consider weaning after this critical period.
https://www.rvc.ac.uk/research/projects/veeph/early-life-determinants-of-performance-and-the-economics-of-thoroughbred-breeding
Reference
According to the researchers, who came from the University of Nottingham School of Veterinary Medicine and Science, Guide Dogs and Feldon Veterinary Centre, this was the first study to compare peri- and postoperative complications, behaviour after surgery, and surgery duration, for the two most common neutering procedures for female dogs; laparoscopic ovariectomy (LAP-OVE) and open ovariohysterectomy (celiotomy) (OVH-CEL).
For the study, the researchers analysed data from 519 bitches neutered by either LAP-OVE or OVH-CEL at four UK veterinary practices.
Fewer bitches developed wound redness or swelling at the surgical site following LAP-OVE (16%), compared to those that underwent OVH-CEL (36%).
Intraoperative complications were reported for 2% of dogs neutered by LAP-OVE and 3% of those neutered by OVH-CEL.
Postoperative complications were reported for 0.5% of the LAP-OVE group and 1% of the OVH-CEL group.
Unusual behaviours (inappetence, discomfort, licking or chewing) in the postoperative period were less common in dogs neutered by laparoscopic ovariectomy.
There was no significant difference in surgical duration between the two techniques.
The researchers say that their findings add to a growing body of evidence suggesting that postoperative complications, including those related to wound healing and those requiring further veterinary intervention, are lower for laparoscopic than open surgeries for bitches neutered by experienced veterinarians.
Lead author, Dr Rachel Moxon, said: “While there is already evidence from other studies relating to complications following neutering surgeries in bitches, this is the first time that the outcomes have been compared between what are anecdotally reported to be the two most frequently performed neutering surgeries for female dogs in the UK.
"The results will be of interest not only to vets, but for pet owners and others that have to make choices about neutering their dogs. Understanding the surgical risks is an important factor to consider, and decision making is made easier when it can be informed by evidence”.
https://onlinelibrary.wiley.com/doi/10.1111/jsap.70013
The guidelines, which are the result of a collaboration between veterinary dermatologists, clinical microbiologists and other specialists, are designed to reduce inappropriate antimicrobial use and help canine welfare.
The team conducted an evidence review and built a consensus of recommendations, combining scientific evidence with real-world insights.
The new guidelines are supported by the ISCAID (International Society for Companion Animal Infections) and provide veterinary practitioners with guidance on the diagnosis and investigation of canine bacterial skin infections.
The guidelines offer recommendations for when antimicrobials should be considered, and which classes of antimicrobials are most appropriate to choose from.
As part of this guidance, recommended drug dosages have also been updated based on newly available information.
The RVC says this will ensure that available antimicrobial drugs can be used as responsibly as possible and remain effective for a long as possible.
RVC has also produced a short synopsis of the main consensus statements and a ‘Seven Moments of Responsible Canine Pyoderma Treatment’ infographic.
Anette Loeffler, Professor in Veterinary Dermatology and Cutaneous Bacteriology at the RVC and chair of the ISCAID author group, said: “After several years of analysing evidence, updating information and evaluating experience, we are excited and relieved to finally see the guideline documents published and free to use around the world.”
https://pubmed.ncbi.nlm.nih.gov/40338805
Senior educators came from both UK and international veterinary and nursing schools to discuss and agree approaches to teaching contextualised care in first opinion practice for the first time.
The workshop aimed to give delegates an understanding of what contextualised care is and why it is important.
It also covered the types of clinical training settings that are conducive to supporting contextualised care learning.
Delegates then discussed the challenges associated with contextualised care learning in community-based clinical training settings.
They included: perceived conflicts between educational and commercial interests, a lack of previous formal teaching of contextualised care (during education), and the absence of established culture (and experience) of undergraduate teaching in clinical practice.
Workshop co-presenter and CVS’ Equine Development Lead Charlotte Sinclair, said: “Most veterinary graduates will enter primary care practice upon graduation and we know the majority of new graduates and employers agree that graduates are not prepared to practice contextualised care. The consequences of not being prepared include a tension between presumed ‘gold standard’ and the realities of practice, stress and moral distress.
“We hope that our landmark workshop will go some way towards helping trainers to support graduates in developing authentic communication skills, building client rapport, creating shared decision making, and being outcome focused. As true contextualised care relies on all of these skills.”
The College wants more vets to come and share their ideas and insights into how the role of the veterinary nurse can be strengthened within the team, particularly in the light of data gathered from the RCVS’s 2024 VN Vision workshops which showed that many nurses believe their skills and capabilities, and the scope of tasks that can be performed within the current legal framework, are not fully used.
The first two events, in South Wales and Belfast, were well-attended by veterinary nurses, but only about 10% of attendees were vets who arguably have the most to gain by sharing ways of enabling nurses to perform a more central role and relieve some of their workload.
There are four more events coming up:
RCVS Director of Veterinary Nursing, Julie Dugmore, said: “Last year’s VN Vision events focused specifically on veterinary nurses and resulted in some truly inspiring insights. Now, in this new series of events, we’re taking the next step, and need to get the wider practice team involved in order to understand how strengthening the VN role will feed into team dynamics and the professions as a whole.
“Our latest VN Vision events will play a key role in helping us to define long term goals, identify the practical steps needed to achieve them, and determine how success will be measured and shared with the wider public. To make it happen, we need voices from vets, practice managers, support staff, and VNs alike.”
The VN Vision workshops are free to attend, informal, informative and made up of small groups.
Supper will also be provided for the evening sessions, and lunch for the London day workshops.
https://www.eventbrite.com/cc/vet-nursing-vision-events-3253639
This, the company says, makes Simparica Trio the only oral moxidectin that is licensed to treat A.vasorum in dogs in the UK.
Louise Longstaff, National Veterinary Manager at Zoetis UK said: “The last time a product was licensed for the treatment of lungworm in the UK was some time ago, so this is an especially important development.
"Simparica Trio offers a new licensed route of administration for lungworm treatment in dogs, giving vets another option to that which is currently available.
"It enables them to tailor treatment based on their patient’s needs while still prescribing within the cascade.”
Simparica Trio is a chewable monthly tablet for dogs containing sarolaner, moxidectin and pyrantel.
It kills fleas and ticks, treats mites, roundworm and hookworm, prevents and treats lungworm and prevents heartworm disease.
https://www.noahcompendium.co.uk/?id=-485011
Giles is the professor of molecular neuroendocrinology at the Medical Research Council Metabolic Diseases Unit and scientific director of the Genomics/Transcriptomics Core at the University of Cambridge.
He is a well-known broadcaster thanks to his appearances on programmes such as BBC’s ‘Horizon’ and ‘Trust me, I’m a Doctor’ and author of two books: Gene Eating: The Story Of Human Appetite and Why Calories Don't Count.
He also hosts the podcast Dr Giles Yeo Chews The Fat.
Giles and his colleagues at the University of Cambridge recently identified a genetic mutation in Labrador retrievers that significantly increases their propensity for obesity and food motivation.
This mutation, a 14-base pair deletion in the POMC gene, disrupts the production of beta-MSH and beta-endorphin, hormones involved in regulating appetite and energy balance.
The study found this mutation is present in about 25% of Labradors and 66% of flat-coated retrievers, and is also more common in assistance dogs than pet Labradors.
Giles' lecture: "The genetics of obesity: Can an old dog teach us new tricks?" will lay out the evidence for a genetic basis to body weight and explore the role of the leptin-melanocortin pathway in both human and dog obesity, and its conservation through evolution.
Giles said: “It is clear that the cause of obesity is a result of eating more than you burn.
"It is physics.
"What is more complex to answer is why some people eat more than others?
"Differences in our genetic make-up mean some of us are slightly more hungry all the time and so eat more than others.
"I will highlight the fat-sensing 'leptin-melanocortin' pathway, as a key appetite control circuit.
"Not only is the pathway conserved in all mammals and many higher vertebrates, but genetic disruption of the pathway as an evolutionary strategy to influence feeding behaviour has also been conserved. In contrast to the prevailing view, obesity is not a choice.
"People who are obese are not bad or lazy; rather, they are fighting their biology.”
British Veterinary Association President Elizabeth Mullineaux said: “I’m sure our BVA Congress delegates will appreciate both Dr Yeo’s scientific knowledge and his dynamic delivery style and I’m personally looking forward to learning more about this exciting topic.”
https://london.vetshow.com
The model was trialled at the group's Rotherham practice where it has introduced advanced soft tissue surgery, 128-slice CT scanning, orthopaedics and spinal surgery, cardiac scanning and ophthalmology.
To offer the service, the group has invested £280K in post-graduate qualifications for its vets and £130k in equipment over the past 18 months.
The Pet Vet Says that not only does the ‘First Opinion Plus’ model expand the group’s ability to serve more pets in their communities, it has also boosted recruitment and retention of clinical colleagues by offering rewarding technical career pathways in addition to traditional leadership routes.
Emily Chapman, Area Manager at The Pet Vet, said: “The implementation of the ‘first opinion plus’ model at The Pet Vet Rotherham has transformed our offering to customers and referring surgeries.
We’ve taken that success and tailored it for each of our 12 surgeries, so every local community we serve benefits from the best of both worlds: trusted first opinion care and advanced services under one roof, as well as a stable and motivated team of colleagues that are supported in pursuing their clinical passions.”
www.thepetvet.co.uk/careers.
The working group, which is led by Gudrun Ravetz, IVC's Group Chief Medical Officer, has been tasked with developing evidence-based, sustainable prescribing practices that protect animal health while safeguarding the planet.
The group comprises experts from within IVC Evidensia’s network who will collaborate with industry and academic partners including Vetoquinol, IDEXX, ESCCAP, and MSD Animal Health to deliver research, education, and practical tools for veterinary teams both inside and outside of IVC Evidensia practices.
Gudrun said: “We’re proud to be investing in this work and setting an example for the profession.
"Responsible parasiticide use is not just a clinical issue, it’s a sustainability imperative.”
Photo: www.depositphotos.com
Faecal calprotectin is a calcium-binding protein released into the gut lumen predominantly by neutrophils, and to a lesser extent by monocytes and macrophages, during intestinal inflammation.
Its presence in faeces reflects the degree of neutrophilic infiltration in the gut mucosa, making it a useful biomarker for identifying intestinal inflammation.
Faecal calprotectin lateral flow testing is already used in human health and included in the NICE guidelines for the management of inflammatory bowel disease (IBD)1.
Determining the underlying cause of chronic diarrhoea, vomiting and weight loss in cats and dogs can be complex, often requiring invasive procedures such as endoscopy or biopsy - both of which carry cost, risk, and sometimes practical limitations in general practice.
GIQuest is designed to offer a non-invasive, rapid alternative to support clinical decision-making.
Carus says that whilst not a replacement for histopathology, faecal calprotectin concentrations have been shown to correlate with disease severity in dogs and cats, as measured by tools such as the Canine Chronic Enteropathy Clinical Activity Index (CCECAI).2
New data from the University of Bristol Vet School appears to confirm the test’s ability to differentiate dogs with histologically-confirmed inflammatory enteropathy from healthy controls with high sensitivity (94%) and specificity (96%) using a score threshold of 3mg/kg.2
Carus says the test also performed well in cats, distinguishing those with inflammatory enteropathy from healthy controls with a specificity of 100% and sensitivity of 92%.
In addition, the test detected elevated calprotectin levels consistent with inflammatory gastroenteropathy in 25% of dogs receiving oral NSAIDs, which highlights its potential not only in long-term monitoring but also early in treatment when GI side effects may first emerge.
Jolian Howell of Carus Animal Health said: “Faecal calprotectin testing can provide additional clarity in a range of clinical scenarios.
"It is particularly useful when diagnosing and managing suspected inflammatory enteropathy or food related reactions and for monitoring or screening for GI side effects of oral non-steroidal anti-inflammatories in long term OA therapy regimes.”
The Bristol study also showed that dogs with food-responsive enteropathy had a significant drop in calprotectin concentrations following dietary change, reinforcing the test’s role in tracking treatment response.
Georgie Louca, Veterinary Business Manager for Carus Animal Health, added: ”By providing a measurable, visual indicator of intestinal inflammation, GIQuest also helps support client communication and can improve compliance during treatment or dietary trials.”
GIQuest is designed for use in practice, including during consultations, delivering colour-coded results in 15 minutes.
GIQuest is now available to veterinary practices across the UK and can be ordered through veterinary wholesalers NVS, Covetrus and MWI.
https://carusanimalhealth.com/giquest
References
They say that the free system offers an easy way for veterinary practices to improve client service, streamline workflows, and enhance animal welfare.
Boop uses AI and computer vision to auto-populate vaccination details and capture things like microchip numbers, to ensure certificates are positively identifiable and compliant with the RCVS 10 principles of certification and electronic signing guidance.
Pet owners can then store and access digital vaccination certificates on their mobile phone through the Boop app, where they can also look-up chip details, up to 30% of which are not properly registered.
The app also lets owners share vaccination certificates easily with boarding and day care establishments via email or whatsapp.
Charlie said: “Boop brings a vaccination record service fit for 2025, enabling vets to add more value to their vaccination service and owners to care better for their pet.
"By linking to the microchip, vets can be confident that every record belongs to the right pet—making care safer, more accurate, and more convenient.”
Once signed up, practices can start issuing digital vaccination certificates immediately, without changing their existing PMS or workflows.
www.booppet.app/vets
The scholarships are designed to support veterinary surgeons who demonstrate exceptional commitment to professional growth and a passion for improving patient outcomes.
Each award covers the tuition fee for the 12-month programmes, including both online learning and practical training sessions.
Applications close for the Small Animal Soft Tissue Scholarship on 15th August 2025, and the Small Animal Medicine Scholarship on the 5th September 2025.
Improve says shortlisted applicants will be assessed based on professional motivation, career aspirations, and commitment to the profession.
https://subscriptions.improveinternational.com/small-animal-medicine-scholarship-2025
https://subscriptions.improveinternational.com/small-animal-soft-tissue-surgery-scholarship-2025
For the study, researchers from the RVC, University of Edinburgh and Scotland’s Rural College analysed data from the RVC’s VetCompass Programme on a random sample of 2,440 nail clipping cases taken from over 2 million dogs under UK primary veterinary practice care during 2019, 5.64% of UK dogs (over one in twenty dogs) were found to have had their nails clipped at least once as part of their primary veterinary care each year.
The nail clipping was the primary reason for attending the veterinary visit for more than half (59.40%) of those dogs.
The most cited clinical reasons for nail clipping veterinary visits were overgrown and/or ingrown nails (12.66%) and broken claws or dewclaws (8.84%).
Of the breeds that were most likely to present for nail-clipping, 13.29% of chihuahuas were clipped each year, 12.58% of beagles, 11.98% of greyhounds and 9.36% of pugs.
Dog breeds with a skull shape that deviated from a typical medium-length skull in either direction also had a higher risk of needing nail clipping.
Flat-faced dogs breeds (e.g. pugs, French bulldogs, shih tzus) were 1.67 times more likely to have their nails clipped, while breeds with long faces (e.g. greyhound, whippet) were 1.32 times more likely to have their nails clipped, compared to breeds with a medium length skull (e.g. Labrador retriever, English springer spaniel).
Dog breeds with shortened and often twisted legs (chondrodystrophic breeds) were also 1.44 times more likely to have their nails clipped compared to dog breeds with straight legs.
Age and body weight also affected a dog’s chances of undergoing nail clipping.
Young dogs aged between 1 to 2 years were the most likely to have nail clipping procedures.
Smaller dogs weighing less than 10.00 kg had higher odds of overgrown nails compared to larger dogs weighing 40.00 kg or more.
The researchers say that frequency of nail clipping in primary veterinary care indicates the need for comprehensive teaching of canine nail care in veterinary and veterinary nursing education, as well as proactive veterinary monitoring, nail care protocols and owner education.
Dr Dan O’Neill, Associate Professor of Companion Animal Epidemiology at the RVC and co-author of the paper, said: “This new VetCompass study shows that some dog breeds have more than twice the need to have their nails clipped compared to other breeds.
"This highlights just how distinct humanity has made each dog breed and suggests we are getting close to the time when we should no longer consider all dog breeds as even being the same species.”
Dr Lavin Ahmed, Veterinary Surgeon, President of Protecting Animals in Kurdistan Organization (PAKO) and lead author of the study, said: “When I was first offered nail clipping by RVC VetCompass as my MSc research topic, I honestly underestimated its significance.
"It seemed like just another routine procedure that we all do every day in veterinary practice.
"However, reading the clinical records made it clear that nail care is more than just a trivial grooming procedure but is a genuine welfare issue that deserves much more attention in both veterinary training and owner education.”
Zenrelia is a new JAK inhibitor which Elanco says provides visible itch relief which lasts 24 hours, from the first dose.1
The company points to a head-to-head study with over 330 dogs across 25 vet clinics, in which Zenrelia was shown to get nearly 50% more itchy dogs back to normal than Apoquel (oclacitinib).1
Elanco says its once-daily dosing may also improve treatment compliance over twice-daily alternatives.
The company also says that Zenrelia has a cost benefit too, presumably meaning it's cheaper than alternatives.
Zenrelia can be given long term with commonly used medications, including vaccines, antibiotics, parasiticides and NSAIDs.
Elanco UK & Ireland General Manager Matthew Frost said: “With this treatment, we’re looking at happier dogs and their owners, and a more rewarding experience for vets.”
www.zenrelia.co.uk
David, Appleton Professor in Equine Surgery, University of Florida (pictured, left), says that despite considerable progress since the 1970's, largely through improved understanding of the diseases involved, diagnostic methods, surgical equipment and materials, and specialised training of surgeons, lingering problems remain and need to be addressed at all levels, not just by surgeons.
He said: “The current high cost of colic surgery can deny many horses a life-saving procedure.
"Pessimism is likely the product of past failures and overemphasis of treatments that are inappropriate or misdirected.
"Delays in referral might seem minor but have devastatingly harmful effects on outcome.
"Owners, primary care veterinarians, and surgeons need to establish an approach to colic based on teamwork, education, and rejection of myths that are widely promulgated.
"I will be looking at the key elements of progress and how they can be applied for future success.”
Professor Scott Weese (pictured right) is Director of the Centre for Public Health and Zoonoses at the University of Guelph.
He will present: "Misconceptions, Myths and Dogmas: moving past old barriers to optimise antimicrobial use in horses", which will challenge the audience to think about what they do with antibiotics and why, with the aim of introducing practical steps to optimise antimicrobial use, leading to improved patient outcomes, easier treatment and minimisation of negative consequences.
Scott said: “We do a lot of things simply because we’ve done them, not because they work or make sense, and we need to look at what we’re doing and the available evidence.
"I will discuss some well-established dogmas that don’t actually make sense, cover some common questions and misconceptions about antibiotic use, and try to help us advance how we use these life-saving drugs that, to some degree, are a non-renewable resource.”
Scott will also be presenting a talk about sampling on the Friday in the antimicrobial stewardship session, with the aim of getting everyone thinking about how we make antibiotic decisions: “There’s a lot of emphasis on submitting cultures, but if we submit bad samples or can’t interpret them, it’s at best a waste of money and at worst can harm patients.”
Book before 6th August to take advantage of early bird prices for BEVA members of £599 for a three-day pass for vets (normal price £699) and £225 for vet nurses (normal price £273) (with concessionary rates available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Early bird rates and practice passes are available until 6 August 2025.
http://www.bevacongress.org
This allows patients to try the drug at lower cost, before progressing to the 30ml bottle for ongoing treatment.
Samantha Taylor, RCVS Recognised Specialist in Feline Medicine said: “It’s great we now have the option to prescribe the smaller 12ML bottle for starting cats on Senvelgo, as it means we don’t have to worry about wasting a 30ml bottle if it becomes evident that the cat requires insulin in the first couple of weeks.”
https://senvelgo.co.uk
The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
To refer a case: https://chestergates.org.uk/referral-services.
The authors say the research marks a significant step forward in understanding how veterinary surgeons and owners can more effectively manage and prevent outbreaks of the disease.
For the study, researchers from the RVC, the University of Cambridge, the Swedish University of Agricultural Sciences and Redwings Horse Sanctuary, analysed more than 500 S. equi samples from across the UK between 2016 and 2022.
In particular, they wanted to better understand the relative contribution of short-term (immediately post infection) versus long-term carriers (carriers that were infected months or years prior).
The samples were collected from clinical cases sent to diagnostic laboratories by veterinary surgeons seeking confirmation of infection.
Surplus samples were submitted to the Surveillance of Equine Strangles network and then cultured in the RVC’s research laboratory and their DNA extracted and sequenced to reveal each bacterium’s complete genetic code.
Adopting an approach that combined whole genome sequencing and epidemiological data, the researchers were able to trace how strains are related and have evolved.
With the use of computer programmes, they also tracked how genetically related strains spread between horses and across regions, over time.
By adopting this approach, the team was also able to pinpoint likely transmission events and chains of infection.
The research highlights the need for early diagnosis, isolation and laboratory-confirmed clearance, particularly through guttural pouch testing, before assuming a horse is infection-free.
It also advocates for tighter biosecurity and movement protocols, especially when transporting horses across regions.
Dr Abigail McGlennon, former PhD student in the Department of Pathobiology and Population Sciences at the RVC, and lead author of the paper, said: “Strangles is a challenging and distressing disease for horses, owners, yards and vets, and this work has highlighted just how easily it can be spread across the UK in a short period of time.
“This study shows how important enhanced surveillance utilising epidemiological and genomic data is to investigate and understand strangles transmission across the UK.
"Our data highlights the importance of greater awareness and adoption of post-outbreak screening protocols to confirm freedom from infection, rather than owners assuming recovery based on the resolution of clinical signs.”
The new Tosoh AIA 900 analysers have been trialled for the last 18 months at Liphook Equine Hospital, which was the first practice to introduce ACTH testing for horses 25 years ago and gets hundreds of blood samples every week from veterinary practices all over the UK and Europe.
Professor Andy Durham, who heads up the laboratory at Liphook, said the test period has shown that the new machine produces more accurate results primarily because it’s less sensitive to ACTH degrading in blood samples between collection and receipt by the laboratory.
Andy said: “There are several analytic methods available for use in horses, and we wanted to see if this alternative machine had diagnostic benefits over the ones we’d used previously.
"The ACTH molecule we test for immediately begins to break down after a blood sample is taken, even if you handle it carefully and place it in chilled packaging, but this new analyser is able to detect much more of the degraded ACTH molecule, and therefore it gives a more accurate result.
“As a comparison, ACTH values measured using the previous method suffered about three to four times more degradation over 24 hours.
"What this means for horse owners is that it will reduce the risk of false negative results in ACTH tests, so more horses suffering from Cushing’s disease will receive the treatment they need.”
In testing, the new analysers also demonstrated greater accuracy when measuring insulin levels in blood samples.
https://liphookequinehospital.co.ukhttps://www.rainbowequinehospital.co.uk https://www.rossdales.com
The project, which launched in September 2022 and was funded by Boehringer Ingelheim, has given subsidised respiratory pathogen investigations to over 300 farms so far.
The investigations revealed a mixture of agents, including: mycoplasma (37%), IBR (6%), P13 (12%), coronavirus (38%), histophilus (48%), RSV (30%), mannheimia (64%), and pasteurella (94%).
Following each investigation, discussions were held between farmer and vet about taking a more preventative approach, considering things like biosecurity, immunity, housing, environmental management, vaccination and treatment protocols.
CVS says the investigations have also enabled its vets to target the right vaccine to the right farm to cover the main risk periods for those animals.
Vaccinations have been timed in relation to peaks in clinical cases and pre-stress periods - such as weaning, group movements or transport to ensure animals are protected against the correct pathogen effectively.
CVS says that taking this preventative herd health measure has resulted in significantly fewer antibiotics being required to treat respiratory infection and disease in the past year.
Steven Carragher, Quality Improvement Farm Lead for CVS and Senior Veterinary Surgeon at Alnorthumbria Vets, said: “Though only running for just over two years, our programme is already yielding significant data, and we’re using this evidence to help each farm successfully implement a range of measures to help prevent and vaccinate against pneumonia – and to reduce antibiotic use.
'Evidence-based veterinary medicine at 20 – a commentary on historical, philosophical, practical, and ethical aspects' by David Mills MRCVS, Michael J. Reiss and Madeleine Campbell FRCVS, looks at the history of both evidence-based medicine and EBVM, the moral and ethical arguments for EBVM and the practical barriers.
It concludes that EBVM would be improved by:
Author David Mills MRCVS said: “EBVM has extensively infiltrated the veterinary discourse in the last 20 years and whilst it seems a sensible way of doing medicine, this doesn't always translate into practical improvements.
"Of course we need to base decisions on evidence, and the more reliable that evidence the better the decisions are likely to be.
"But is EBVM the best way?
"Does it serve the individual when the evidence doesn't relate to them or the specifics of their disease?
"Does EBVM help or hinder us in realising welfare improvements for the individual animal?
"In this review of the EBVM movement we examine aspects of the methodology and its practical application and in several areas find it wanting.
"Some of these are practical issues - for example underpowered studies, poor evidence - whilst others are fundamental to the philosophy and practice of EBVM itself such as what is evidence, how it translates to individuals and how we cannot predict the future.
"Evidence-based medicine was forged in the fires of not just accepting eminent pronouncements - in this paper we apply this principle to EBVM itself."
https://veterinaryevidence.org/index.php/ve/article/view/710
The RCVS Regional Question Time sessions give members of the profession a chance to learn about College projects and initiatives directly from the RCVS Officer team, Council members, and senior staff.
There is also an opportunity for open dialogue, where any queries can be raised with the RCVS, in a friendly, informal environment.
Both events will begin with supper and drinks at 6.30pm.
The College says discussion topics will be audience-led but are likely to cover current important topics including workforce issues, the benefits of a new Veterinary Surgeons Act, extra-mural studies (EMS), governance reform, the impact of VetGDP, the Practice Standards Scheme (PSS), and the Competition and Markets Authority investigation.
RCVS President, Tim Parkin, said: “It’s an exciting time for me as I embark on my presidential year, and I’m truly looking forward to engaging with members of our wonderful professions about the issues that matter most to them.
“As I mentioned previously at Royal College Day, we’re currently facing some significant and ongoing challenges – from the CMA investigation and workforce issues, to the critical need for a new Veterinary Surgeons Act.
“Now more than ever, it's essential that we recognise the need for change and commit to engaging with one another in a clear, compassionate, and respectful way.
"Please do come and speak with us at either event – meaningful change cannot happen in silos; we must work together to make progress and your input is key.”
https://www.eventbrite.com/cc/rcvs-question-time-4465993
The one-day course covers a variety of procedures, from forelimb, hindlimb and tail amputations, to enucleations and simple eyelid mass removals.
Graduates will also begin learning about the use of basic skin flaps to close larger wounds.
They will also be taught how to recognise a patient requiring urgent or emergency care and initiate evaluation and management.
Sarah Rutherford, Head of Clinical Education at CVS, said: “When we spoke to our graduates, they told us that they were keen for us to run this course, so that they could build experience and confidence in these common procedures, post their university and extra mural training.
“These are GP procedures. So, thinking about contextualised care, we felt it was important for all of our companion animal veterinary General Practitioners to offer these treatment options - no matter how many years they’d been practicing.
"It’s great to empower our new graduates to conduct these salvage-type procedures - rather than book them in with experienced, certified and advanced vets, or even a referrals specialist.
“It was also important for us to have GP vets Frances and Andy teaching our new surgical GP course, as they appreciate the challenges and practicalities of first opinion practice (FOP).
"It hopefully shows the opportunities that are available in teaching within CVS for all of our general practitioners.”
Hannah Spooner BVSc MRCVS, New Graduate Programme Lead said: "I recently took at poll at the Cambridge AVS congress this spring and this course came out on top - as the course students would ‘most be looking forward to’ if they were to join the CVS New graduate programme in the future. So that’s very encouraging to know!”
www.careerswithcvs.co.uk
The Ageing Canine Toolkit, which was developed from research carried out by the University of Liverpool, aims to help both vets and owners provide the best care for senior and geriatric dogs.
It includes information about common health problems that affect ageing dogs and a colour-coded checklist to help owners know when to seek advice from a veterinary practice and how to guide discussions during consultations.
As part of the partnership, NationWide Laboratories will be distributing the toolkit to its clients, helping raise awareness and make sure that the owners of older dogs know how to look for signs of disease which could enable treatment to be started earlier.
Alison Selby, Fundraising Manager for BSAVA PetSavers said: “We are thrilled to be embarking on this partnership with NationWide Laboratories.
"By supporting the print and distribution costs of this invaluable resource, they will help us reach more pet owners across the UK.
"Working together in partnership, we hope to equip owners with the knowledge and confidence to support their dogs through the ageing process, ultimately improving their quality of life.”
https://bsava.com/petsavers/our-impact/citizen-science-project